Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort. Issue 5 (May 2020)
- Record Type:
- Journal Article
- Title:
- Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort. Issue 5 (May 2020)
- Main Title:
- Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status
- Authors:
- Lazenby, Gweneth B.
Hill, Allyson
Tarleton, Jessica
Soper, David - Abstract:
- Abstract : Background: Trichomonas vaginalis is a common treatable sexually transmitted infection among older women. Persistent T. vaginalis infection after treatment is common among women with human immunodeficiency virus (HIV). We sought to determine if HIV-negative women were as likely as women with HIV to have persistent T. vaginalis infection. Methods: We performed a retrospective cohort study of women 45 years or older with T. vaginalis infection. We evaluated differences in persistent T. vaginalis infection according to HIV status using χ 2 analysis. We performed regression analyses to describe factors associated with persistent and recurrent infection in older women. Results: Over a 10-year study period, we identified 282 women with T. vaginalis, 46 with HIV. Most women (240, 86%) were treated in accordance with 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases treatment guidelines. Half of the women (144, 53%) had a repeat T. vaginalis test 90 to 365 days after treatment, and one third had persistent infection (39/125, 31%). Persistent infection was similar between women with HIV and HIV-negative women treated according to Centers for Disease Control recommendations (17% vs 33%, P = 0.3). When adjusting for age and incidental diagnosis, tobacco use was associated with an increased risk of more than 1 or recurrent T. vaginalis infection during the study period (adjusted odds ratio, 2.8; 95% confidence interval, 1.5–4.9). Conclusions: TheAbstract : Background: Trichomonas vaginalis is a common treatable sexually transmitted infection among older women. Persistent T. vaginalis infection after treatment is common among women with human immunodeficiency virus (HIV). We sought to determine if HIV-negative women were as likely as women with HIV to have persistent T. vaginalis infection. Methods: We performed a retrospective cohort study of women 45 years or older with T. vaginalis infection. We evaluated differences in persistent T. vaginalis infection according to HIV status using χ 2 analysis. We performed regression analyses to describe factors associated with persistent and recurrent infection in older women. Results: Over a 10-year study period, we identified 282 women with T. vaginalis, 46 with HIV. Most women (240, 86%) were treated in accordance with 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases treatment guidelines. Half of the women (144, 53%) had a repeat T. vaginalis test 90 to 365 days after treatment, and one third had persistent infection (39/125, 31%). Persistent infection was similar between women with HIV and HIV-negative women treated according to Centers for Disease Control recommendations (17% vs 33%, P = 0.3). When adjusting for age and incidental diagnosis, tobacco use was associated with an increased risk of more than 1 or recurrent T. vaginalis infection during the study period (adjusted odds ratio, 2.8; 95% confidence interval, 1.5–4.9). Conclusions: The HIV status did not affect persistent T. vaginalis infection in women 45 years or older. Given over one third of women have a positive test within a year after the recommended treatment, our data support repeat testing in women 45 years and older treated for T. vaginalis . Abstract : Persistent Trichomonas vaginalis infection is common among women 45 years and older. Human immunodeficiency virus status was not associated with persistent or recurrent infection. More effective treatment strategies are needed. … (more)
- Is Part Of:
- Sexually transmitted diseases. Volume 47:Issue 5(2020)
- Journal:
- Sexually transmitted diseases
- Issue:
- Volume 47:Issue 5(2020)
- Issue Display:
- Volume 47, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 47
- Issue:
- 5
- Issue Sort Value:
- 2020-0047-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-05
- Subjects:
- Sexually transmitted diseases -- Periodicals
Sexual health -- Periodicals
616.951005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00007435-000000000-00000 ↗
http://www.stdjournal.com ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/OLQ.0000000000001159 ↗
- Languages:
- English
- ISSNs:
- 0148-5717
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8254.486500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13765.xml